1. 1Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
2. 2Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
3. 3Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tübingen, Tübingen, Germany.
4. 4Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
5. 5Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
6. 6Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, California.
7. 7Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
8. 8Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
9. 9Faculty of Medicine, Medical Center, Institute of Medical Bioinformatics and Systems Medicine (IBSM), University of Freiburg, Germany.
10. 10Department of Medicine I, University Hospital of Dresden, Dresden, Germany.
11. 11Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.
12. 12Department of Otorhinolaryngology, Head and Neck Surgery, University of Tübingen, Tübingen, Germany.
13. 13Rudolf-Virchow-Zentrum, University Würzburg, Würzburg, Germany.
14. 14German Bone Marrow Donor Center (DKMS), Clinical Trials Unit, Dresden, Germany.
15. 15Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
16. 16National Center for Tumor Diseases (NCT), University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
17. 17German Cancer Consortium (DKTK), partner site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
18. 18Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
19. 19German Cancer Consortium (DKTK), Partner Site, Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
20. 20Centre for Integrative Biological Signalling Studies (CIBSS), University of Freiburg, Freiburg, Germany.
21. 21Clinic for Hematology, University of Basel and University Hospital Basel, Basel, Switzerland.
22. 22German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Germany.
23. 23Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California.